The U.S. Food and Drug Administration said on Wednesday it had authorized state-licensed pharmacists to prescribe Pfizer Inc’s (PFE.N) COVID-19 pill to eligible patients to help improve access to the treatment.
The antiviral drug, Paxlovid, has been cleared for use and available for free in the United States since December, but fewer than half of the nearly 4 million courses distributed to pharmacies by the government so far have been administered…
